nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—Clofarabine—hematologic cancer	0.109	0.297	CrCtD
Ribavirin—Nelarabine—hematologic cancer	0.103	0.279	CrCtD
Ribavirin—Fludarabine—hematologic cancer	0.0803	0.218	CrCtD
Ribavirin—Cytarabine—hematologic cancer	0.0758	0.206	CrCtD
Ribavirin—IMPDH1—Tioguanine—hematologic cancer	0.0755	0.31	CbGbCtD
Ribavirin—SLC28A3—Fludarabine—hematologic cancer	0.0378	0.155	CbGbCtD
Ribavirin—SLC29A1—Fludarabine—hematologic cancer	0.0251	0.103	CbGbCtD
Ribavirin—SLC28A3—Cladribine—hematologic cancer	0.0244	0.1	CbGbCtD
Ribavirin—SLC28A3—Mercaptopurine—hematologic cancer	0.0227	0.0929	CbGbCtD
Ribavirin—SLC29A1—Cytarabine—hematologic cancer	0.0171	0.0703	CbGbCtD
Ribavirin—SLC28A3—Gemcitabine—hematologic cancer	0.0157	0.0644	CbGbCtD
Ribavirin—SLC29A1—Mercaptopurine—hematologic cancer	0.0151	0.0618	CbGbCtD
Ribavirin—SLC29A1—Gemcitabine—hematologic cancer	0.0104	0.0428	CbGbCtD
Ribavirin—Glucosamine—Cytarabine—hematologic cancer	0.00745	0.0291	CrCrCtD
Ribavirin—Regadenoson—Clofarabine—hematologic cancer	0.00698	0.0273	CrCrCtD
Ribavirin—S-Adenosylmethionine—Clofarabine—hematologic cancer	0.00698	0.0273	CrCrCtD
Ribavirin—Regadenoson—Nelarabine—hematologic cancer	0.00657	0.0257	CrCrCtD
Ribavirin—S-Adenosylmethionine—Nelarabine—hematologic cancer	0.00657	0.0257	CrCrCtD
Ribavirin—Clofarabine—Nelarabine—hematologic cancer	0.00657	0.0257	CrCrCtD
Ribavirin—Fludarabine—Clofarabine—hematologic cancer	0.00655	0.0256	CrCrCtD
Ribavirin—Azacitidine—Pentostatin—hematologic cancer	0.00622	0.0243	CrCrCtD
Ribavirin—Adenosine—Pentostatin—hematologic cancer	0.00622	0.0243	CrCrCtD
Ribavirin—Vidarabine—Pentostatin—hematologic cancer	0.00622	0.0243	CrCrCtD
Ribavirin—Adenosine monophosphate—Clofarabine—hematologic cancer	0.00617	0.0241	CrCrCtD
Ribavirin—Nelarabine—Clofarabine—hematologic cancer	0.00617	0.0241	CrCrCtD
Ribavirin—Fludarabine—Nelarabine—hematologic cancer	0.00616	0.0241	CrCrCtD
Ribavirin—Cytarabine—Clofarabine—hematologic cancer	0.00584	0.0228	CrCrCtD
Ribavirin—Adenosine monophosphate—Nelarabine—hematologic cancer	0.0058	0.0227	CrCrCtD
Ribavirin—Adenosine—Clofarabine—hematologic cancer	0.00555	0.0217	CrCrCtD
Ribavirin—Azacitidine—Clofarabine—hematologic cancer	0.00555	0.0217	CrCrCtD
Ribavirin—Vidarabine—Clofarabine—hematologic cancer	0.00555	0.0217	CrCrCtD
Ribavirin—Cytarabine—Nelarabine—hematologic cancer	0.00549	0.0215	CrCrCtD
Ribavirin—Vidarabine—Nelarabine—hematologic cancer	0.00522	0.0204	CrCrCtD
Ribavirin—Adenosine—Nelarabine—hematologic cancer	0.00522	0.0204	CrCrCtD
Ribavirin—Azacitidine—Nelarabine—hematologic cancer	0.00522	0.0204	CrCrCtD
Ribavirin—Regadenoson—Fludarabine—hematologic cancer	0.00513	0.02	CrCrCtD
Ribavirin—S-Adenosylmethionine—Fludarabine—hematologic cancer	0.00513	0.02	CrCrCtD
Ribavirin—Clofarabine—Fludarabine—hematologic cancer	0.00513	0.02	CrCrCtD
Ribavirin—Regadenoson—Cytarabine—hematologic cancer	0.00484	0.0189	CrCrCtD
Ribavirin—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.00484	0.0189	CrCrCtD
Ribavirin—Clofarabine—Cytarabine—hematologic cancer	0.00484	0.0189	CrCrCtD
Ribavirin—Regadenoson—Cladribine—hematologic cancer	0.00472	0.0184	CrCrCtD
Ribavirin—Clofarabine—Cladribine—hematologic cancer	0.00472	0.0184	CrCrCtD
Ribavirin—Fludarabine—Cytarabine—hematologic cancer	0.00454	0.0178	CrCrCtD
Ribavirin—Adenosine monophosphate—Fludarabine—hematologic cancer	0.00453	0.0177	CrCrCtD
Ribavirin—Nelarabine—Fludarabine—hematologic cancer	0.00453	0.0177	CrCrCtD
Ribavirin—Fludarabine—Cladribine—hematologic cancer	0.00442	0.0173	CrCrCtD
Ribavirin—Cytarabine—Fludarabine—hematologic cancer	0.00429	0.0168	CrCrCtD
Ribavirin—Adenosine monophosphate—Cytarabine—hematologic cancer	0.00428	0.0167	CrCrCtD
Ribavirin—Nelarabine—Cytarabine—hematologic cancer	0.00428	0.0167	CrCrCtD
Ribavirin—Adenosine monophosphate—Cladribine—hematologic cancer	0.00417	0.0163	CrCrCtD
Ribavirin—Nelarabine—Cladribine—hematologic cancer	0.00417	0.0163	CrCrCtD
Ribavirin—Vidarabine—Fludarabine—hematologic cancer	0.00407	0.0159	CrCrCtD
Ribavirin—Azacitidine—Fludarabine—hematologic cancer	0.00407	0.0159	CrCrCtD
Ribavirin—Adenosine—Fludarabine—hematologic cancer	0.00407	0.0159	CrCrCtD
Ribavirin—Cytarabine—Gemcitabine—hematologic cancer	0.00405	0.0158	CrCrCtD
Ribavirin—Adenosine—Cytarabine—hematologic cancer	0.00385	0.015	CrCrCtD
Ribavirin—Vidarabine—Cytarabine—hematologic cancer	0.00385	0.015	CrCrCtD
Ribavirin—Azacitidine—Gemcitabine—hematologic cancer	0.00385	0.015	CrCrCtD
Ribavirin—Azacitidine—Cytarabine—hematologic cancer	0.00385	0.015	CrCrCtD
Ribavirin—Vidarabine—Cladribine—hematologic cancer	0.00375	0.0147	CrCrCtD
Ribavirin—Azacitidine—Cladribine—hematologic cancer	0.00375	0.0147	CrCrCtD
Ribavirin—Adenosine—Cladribine—hematologic cancer	0.00375	0.0147	CrCrCtD
Ribavirin—ENPP1—hematopoietic system—hematologic cancer	0.00134	0.0722	CbGeAlD
Ribavirin—NT5C2—hematopoietic system—hematologic cancer	0.000981	0.0527	CbGeAlD
Ribavirin—ENPP1—blood—hematologic cancer	0.000889	0.0478	CbGeAlD
Ribavirin—IMPDH1—hematopoietic system—hematologic cancer	0.000796	0.0428	CbGeAlD
Ribavirin—ENPP1—lung—hematologic cancer	0.00078	0.0419	CbGeAlD
Ribavirin—SLC28A3—bone marrow—hematologic cancer	0.000755	0.0406	CbGeAlD
Ribavirin—NT5C2—gonad—hematologic cancer	0.000746	0.0401	CbGeAlD
Ribavirin—ENPP1—testis—hematologic cancer	0.000736	0.0395	CbGeAlD
Ribavirin—SLC28A3—lung—hematologic cancer	0.000684	0.0368	CbGeAlD
Ribavirin—NT5C2—blood—hematologic cancer	0.00065	0.0349	CbGeAlD
Ribavirin—NT5C2—bone marrow—hematologic cancer	0.000629	0.0338	CbGeAlD
Ribavirin—ADK—hematopoietic system—hematologic cancer	0.000628	0.0337	CbGeAlD
Ribavirin—NT5C2—lung—hematologic cancer	0.00057	0.0306	CbGeAlD
Ribavirin—NT5C2—testis—hematologic cancer	0.000537	0.0289	CbGeAlD
Ribavirin—SLC29A1—hematopoietic system—hematologic cancer	0.000534	0.0287	CbGeAlD
Ribavirin—ENPP1—lymph node—hematologic cancer	0.000533	0.0287	CbGeAlD
Ribavirin—IMPDH1—blood—hematologic cancer	0.000527	0.0284	CbGeAlD
Ribavirin—IMPDH1—bone marrow—hematologic cancer	0.00051	0.0274	CbGeAlD
Ribavirin—ADK—gonad—hematologic cancer	0.000477	0.0256	CbGeAlD
Ribavirin—IMPDH1—lung—hematologic cancer	0.000462	0.0249	CbGeAlD
Ribavirin—IMPDH1—testis—hematologic cancer	0.000436	0.0235	CbGeAlD
Ribavirin—ADK—blood—hematologic cancer	0.000416	0.0223	CbGeAlD
Ribavirin—SLC29A1—gonad—hematologic cancer	0.000406	0.0218	CbGeAlD
Ribavirin—ADK—bone marrow—hematologic cancer	0.000402	0.0216	CbGeAlD
Ribavirin—NT5C2—lymph node—hematologic cancer	0.00039	0.0209	CbGeAlD
Ribavirin—ADK—lung—hematologic cancer	0.000364	0.0196	CbGeAlD
Ribavirin—SLC29A1—blood—hematologic cancer	0.000354	0.019	CbGeAlD
Ribavirin—ADK—testis—hematologic cancer	0.000344	0.0185	CbGeAlD
Ribavirin—SLC29A1—bone marrow—hematologic cancer	0.000343	0.0184	CbGeAlD
Ribavirin—IMPDH1—lymph node—hematologic cancer	0.000316	0.017	CbGeAlD
Ribavirin—SLC29A1—lung—hematologic cancer	0.00031	0.0167	CbGeAlD
Ribavirin—SLC29A1—testis—hematologic cancer	0.000293	0.0157	CbGeAlD
Ribavirin—Azacitidine—DNMT3A—hematologic cancer	0.000261	0.148	CrCbGaD
Ribavirin—ADK—lymph node—hematologic cancer	0.000249	0.0134	CbGeAlD
Ribavirin—Azacitidine—CDA—hematologic cancer	0.000232	0.132	CrCbGaD
Ribavirin—SLC29A1—lymph node—hematologic cancer	0.000212	0.0114	CbGeAlD
Ribavirin—Nelarabine—DCK—hematologic cancer	0.000192	0.109	CrCbGaD
Ribavirin—Clofarabine—DCK—hematologic cancer	0.000187	0.106	CrCbGaD
Ribavirin—Fludarabine—DCK—hematologic cancer	0.000181	0.103	CrCbGaD
Ribavirin—Cytarabine—CDA—hematologic cancer	0.000133	0.0752	CrCbGaD
Ribavirin—Glucosamine—IFNG—hematologic cancer	0.00012	0.0679	CrCbGaD
Ribavirin—Adenosine monophosphate—CREB1—hematologic cancer	0.00012	0.0679	CrCbGaD
Ribavirin—Cytarabine—DCK—hematologic cancer	0.000117	0.0662	CrCbGaD
Ribavirin—ENPP1—Dexamethasone—Betamethasone—hematologic cancer	9.98e-05	0.131	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Dexamethasone—hematologic cancer	9.98e-05	0.131	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Triamcinolone—hematologic cancer	9.75e-05	0.128	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Triamcinolone—hematologic cancer	9.75e-05	0.128	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Prednisone—hematologic cancer	9.26e-05	0.122	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Prednisone—hematologic cancer	9.26e-05	0.122	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Prednisolone—hematologic cancer	9.03e-05	0.119	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Prednisolone—hematologic cancer	9.03e-05	0.119	CbGdCrCtD
Ribavirin—Glucosamine—TNF—hematologic cancer	5.01e-05	0.0284	CrCbGaD
Ribavirin—Adenosine monophosphate—SRC—hematologic cancer	4.84e-05	0.0274	CrCbGaD
Ribavirin—Adenosine monophosphate—PDE4B—hematologic cancer	4.33e-05	0.0245	CrCbGaD
Ribavirin—Clofarabine—ABCG2—hematologic cancer	4.22e-05	0.0239	CrCbGaD
Ribavirin—Cytarabine—SLC22A1—hematologic cancer	3.77e-05	0.0214	CrCbGaD
Ribavirin—NT5C2—Metabolism—IDH1—hematologic cancer	1.99e-05	0.000632	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—IDH1—hematologic cancer	1.99e-05	0.000632	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.99e-05	0.000631	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CST3—hematologic cancer	1.98e-05	0.000629	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.97e-05	0.000627	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ADCY7—hematologic cancer	1.97e-05	0.000625	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ABCC3—hematologic cancer	1.96e-05	0.000624	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ABCC3—hematologic cancer	1.96e-05	0.000624	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TXN—hematologic cancer	1.96e-05	0.000624	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTO1—hematologic cancer	1.96e-05	0.000624	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TXN—hematologic cancer	1.96e-05	0.000624	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTO1—hematologic cancer	1.96e-05	0.000624	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NUP214—hematologic cancer	1.95e-05	0.00062	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.94e-05	0.000616	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.93e-05	0.000614	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—HRAS—hematologic cancer	1.93e-05	0.000613	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SPHK1—hematologic cancer	1.92e-05	0.000611	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SPHK1—hematologic cancer	1.92e-05	0.000611	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MTR—hematologic cancer	1.91e-05	0.000608	CbGpPWpGaD
Ribavirin—ENPP1—Disease—XIAP—hematologic cancer	1.91e-05	0.000608	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—IDH2—hematologic cancer	1.88e-05	0.000599	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—HMMR—hematologic cancer	1.88e-05	0.000599	CbGpPWpGaD
Ribavirin—ADK—Metabolism—FHL2—hematologic cancer	1.88e-05	0.000599	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ENO2—hematologic cancer	1.88e-05	0.000596	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SMARCA4—hematologic cancer	1.86e-05	0.000592	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—UGT1A1—hematologic cancer	1.85e-05	0.000587	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—UGT1A1—hematologic cancer	1.85e-05	0.000587	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AGRN—hematologic cancer	1.85e-05	0.000587	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC22A1—hematologic cancer	1.8e-05	0.000571	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SLC22A1—hematologic cancer	1.8e-05	0.000571	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CRABP1—hematologic cancer	1.8e-05	0.000571	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CRABP1—hematologic cancer	1.8e-05	0.000571	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SDC1—hematologic cancer	1.78e-05	0.000565	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ARNTL—hematologic cancer	1.77e-05	0.000563	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ALOX5—hematologic cancer	1.75e-05	0.000557	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ALOX5—hematologic cancer	1.75e-05	0.000557	CbGpPWpGaD
Ribavirin—ADK—Metabolism—IDH2—hematologic cancer	1.75e-05	0.000557	CbGpPWpGaD
Ribavirin—ADK—Metabolism—HMMR—hematologic cancer	1.75e-05	0.000557	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ACP5—hematologic cancer	1.72e-05	0.000548	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CA9—hematologic cancer	1.72e-05	0.000548	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.72e-05	0.000547	CbGpPWpGaD
Ribavirin—ENPP1—Disease—LCK—hematologic cancer	1.72e-05	0.000547	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—AKT1—hematologic cancer	1.7e-05	0.000541	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NCOR2—hematologic cancer	1.7e-05	0.00054	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NUP98—hematologic cancer	1.7e-05	0.000539	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NUP98—hematologic cancer	1.7e-05	0.000539	CbGpPWpGaD
Ribavirin—ENPP1—Disease—H3F3A—hematologic cancer	1.69e-05	0.000536	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NCOA3—hematologic cancer	1.65e-05	0.000523	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ADCY7—hematologic cancer	1.65e-05	0.000523	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ADCY7—hematologic cancer	1.65e-05	0.000523	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NCOA3—hematologic cancer	1.65e-05	0.000523	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ARNTL—hematologic cancer	1.65e-05	0.000523	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PRKCZ—hematologic cancer	1.64e-05	0.000521	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NUP214—hematologic cancer	1.64e-05	0.00052	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NUP214—hematologic cancer	1.64e-05	0.00052	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—IDH1—hematologic cancer	1.62e-05	0.000515	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.62e-05	0.000514	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CALR—hematologic cancer	1.61e-05	0.000512	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTO1—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ABCC3—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TXN—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ABCG2—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—MTR—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ABCG2—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—MTR—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ACP5—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CA9—hematologic cancer	1.6e-05	0.000509	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PARP1—hematologic cancer	1.58e-05	0.000504	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NCOR2—hematologic cancer	1.58e-05	0.000502	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ENO2—hematologic cancer	1.57e-05	0.000499	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ENO2—hematologic cancer	1.57e-05	0.000499	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SPHK1—hematologic cancer	1.57e-05	0.000498	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FBXW7—hematologic cancer	1.56e-05	0.000495	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HDAC2—hematologic cancer	1.53e-05	0.000486	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CXCR4—hematologic cancer	1.53e-05	0.000486	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTT1—hematologic cancer	1.52e-05	0.000484	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTT1—hematologic cancer	1.52e-05	0.000484	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CD44—hematologic cancer	1.51e-05	0.00048	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—UGT1A1—hematologic cancer	1.51e-05	0.000479	CbGpPWpGaD
Ribavirin—ADK—Metabolism—IDH1—hematologic cancer	1.51e-05	0.000479	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CBL—hematologic cancer	1.49e-05	0.000474	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SDC1—hematologic cancer	1.49e-05	0.000473	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SDC1—hematologic cancer	1.49e-05	0.000473	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TXN—hematologic cancer	1.49e-05	0.000473	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTO1—hematologic cancer	1.49e-05	0.000473	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ABCC3—hematologic cancer	1.49e-05	0.000473	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.48e-05	0.000472	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CRABP1—hematologic cancer	1.47e-05	0.000466	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SLC22A1—hematologic cancer	1.47e-05	0.000466	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SPHK1—hematologic cancer	1.46e-05	0.000463	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.45e-05	0.000459	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ALOX5—hematologic cancer	1.43e-05	0.000454	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HSP90AA1—hematologic cancer	1.42e-05	0.000452	CbGpPWpGaD
Ribavirin—ADK—Metabolism—UGT1A1—hematologic cancer	1.4e-05	0.000445	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NUP98—hematologic cancer	1.38e-05	0.000439	CbGpPWpGaD
Ribavirin—ENPP1—Disease—STAT1—hematologic cancer	1.37e-05	0.000436	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SLC22A1—hematologic cancer	1.36e-05	0.000433	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CRABP1—hematologic cancer	1.36e-05	0.000433	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ADCY7—hematologic cancer	1.34e-05	0.000427	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NCOA3—hematologic cancer	1.34e-05	0.000427	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NUP214—hematologic cancer	1.33e-05	0.000424	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ALOX5—hematologic cancer	1.33e-05	0.000422	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—MTR—hematologic cancer	1.31e-05	0.000415	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ABCG2—hematologic cancer	1.31e-05	0.000415	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NUP98—hematologic cancer	1.29e-05	0.000409	CbGpPWpGaD
Ribavirin—ENPP1—Disease—GRB2—hematologic cancer	1.28e-05	0.000408	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ENO2—hematologic cancer	1.28e-05	0.000407	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PDGFA—hematologic cancer	1.28e-05	0.000407	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NQO1—hematologic cancer	1.27e-05	0.000402	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NQO1—hematologic cancer	1.27e-05	0.000402	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CD44—hematologic cancer	1.27e-05	0.000402	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CD44—hematologic cancer	1.27e-05	0.000402	CbGpPWpGaD
Ribavirin—ENPP1—Disease—KITLG—hematologic cancer	1.26e-05	0.000401	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ADCY7—hematologic cancer	1.25e-05	0.000397	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NCOA3—hematologic cancer	1.25e-05	0.000397	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTT1—hematologic cancer	1.24e-05	0.000395	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NUP214—hematologic cancer	1.24e-05	0.000394	CbGpPWpGaD
Ribavirin—ENPP1—Disease—STAT5A—hematologic cancer	1.23e-05	0.000392	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CDKN2B—hematologic cancer	1.22e-05	0.000388	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SDC1—hematologic cancer	1.21e-05	0.000386	CbGpPWpGaD
Ribavirin—ADK—Metabolism—MTR—hematologic cancer	1.21e-05	0.000386	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ABCG2—hematologic cancer	1.21e-05	0.000386	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.21e-05	0.000383	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYCS—hematologic cancer	1.2e-05	0.000381	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYCS—hematologic cancer	1.2e-05	0.000381	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—HSP90AA1—hematologic cancer	1.19e-05	0.000378	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—HSP90AA1—hematologic cancer	1.19e-05	0.000378	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ENO2—hematologic cancer	1.19e-05	0.000378	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CD86—hematologic cancer	1.18e-05	0.000376	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HES1—hematologic cancer	1.17e-05	0.00037	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NCOR1—hematologic cancer	1.16e-05	0.000368	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTT1—hematologic cancer	1.15e-05	0.000367	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FGF1—hematologic cancer	1.15e-05	0.000364	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FOXO1—hematologic cancer	1.13e-05	0.000359	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SDC1—hematologic cancer	1.13e-05	0.000359	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PDGFRB—hematologic cancer	1.13e-05	0.000358	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PDGFRA—hematologic cancer	1.11e-05	0.000353	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PRKCG—hematologic cancer	1.11e-05	0.000351	CbGpPWpGaD
Ribavirin—ENPP1—Disease—JAK1—hematologic cancer	1.11e-05	0.000351	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.08e-05	0.000344	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTP1—hematologic cancer	1.06e-05	0.000336	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTP1—hematologic cancer	1.06e-05	0.000336	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CD44—hematologic cancer	1.03e-05	0.000328	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NQO1—hematologic cancer	1.03e-05	0.000328	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MTHFR—hematologic cancer	1.02e-05	0.000325	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HLA-A—hematologic cancer	1.02e-05	0.000325	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TERT—hematologic cancer	1.02e-05	0.000325	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.01e-05	0.000322	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ABCB1—hematologic cancer	1e-05	0.000318	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ABCB1—hematologic cancer	1e-05	0.000318	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PDGFB—hematologic cancer	9.97e-06	0.000317	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CYCS—hematologic cancer	9.77e-06	0.00031	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TSC2—hematologic cancer	9.74e-06	0.00031	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—HSP90AA1—hematologic cancer	9.7e-06	0.000308	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTM1—hematologic cancer	9.7e-06	0.000308	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTM1—hematologic cancer	9.7e-06	0.000308	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NCOR1—hematologic cancer	9.7e-06	0.000308	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NCOR1—hematologic cancer	9.7e-06	0.000308	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CD44—hematologic cancer	9.6e-06	0.000305	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NQO1—hematologic cancer	9.6e-06	0.000305	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FGFR3—hematologic cancer	9.37e-06	0.000298	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CYCS—hematologic cancer	9.08e-06	0.000289	CbGpPWpGaD
Ribavirin—ADK—Metabolism—HSP90AA1—hematologic cancer	9.02e-06	0.000287	CbGpPWpGaD
Ribavirin—ENPP1—Disease—BAD—hematologic cancer	8.88e-06	0.000282	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NOTCH1—hematologic cancer	8.8e-06	0.00028	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CD80—hematologic cancer	8.62e-06	0.000274	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTP1—hematologic cancer	8.61e-06	0.000274	CbGpPWpGaD
Ribavirin—ENPP1—Disease—KIT—hematologic cancer	8.6e-06	0.000273	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—MTHFR—hematologic cancer	8.58e-06	0.000273	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—MTHFR—hematologic cancer	8.58e-06	0.000273	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTPN11—hematologic cancer	8.45e-06	0.000269	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CREB1—hematologic cancer	8.19e-06	0.00026	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ABCB1—hematologic cancer	8.15e-06	0.000259	CbGpPWpGaD
Ribavirin—ENPP1—Disease—BRAF—hematologic cancer	8.09e-06	0.000257	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.06e-06	0.000256	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTP1—hematologic cancer	8e-06	0.000254	CbGpPWpGaD
Ribavirin—ENPP1—Disease—IL6R—hematologic cancer	7.99e-06	0.000254	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CREBBP—hematologic cancer	7.98e-06	0.000254	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NCOR1—hematologic cancer	7.91e-06	0.000251	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTM1—hematologic cancer	7.91e-06	0.000251	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MAP2K1—hematologic cancer	7.61e-06	0.000242	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ABCB1—hematologic cancer	7.58e-06	0.000241	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3CD—hematologic cancer	7.56e-06	0.00024	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ALB—hematologic cancer	7.54e-06	0.00024	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTM1—hematologic cancer	7.35e-06	0.000234	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NCOR1—hematologic cancer	7.35e-06	0.000234	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FGF2—hematologic cancer	7.24e-06	0.00023	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CG—hematologic cancer	7.21e-06	0.000229	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CG—hematologic cancer	7.21e-06	0.000229	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3R1—hematologic cancer	7.14e-06	0.000227	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—MTHFR—hematologic cancer	6.99e-06	0.000222	CbGpPWpGaD
Ribavirin—ENPP1—Disease—JAK2—hematologic cancer	6.94e-06	0.000221	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MDM2—hematologic cancer	6.78e-06	0.000215	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CREBBP—hematologic cancer	6.68e-06	0.000212	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CREBBP—hematologic cancer	6.68e-06	0.000212	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MTOR—hematologic cancer	6.59e-06	0.00021	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3CB—hematologic cancer	6.59e-06	0.00021	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CD4—hematologic cancer	6.58e-06	0.000209	CbGpPWpGaD
Ribavirin—ADK—Metabolism—MTHFR—hematologic cancer	6.5e-06	0.000207	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CD—hematologic cancer	6.33e-06	0.000201	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CD—hematologic cancer	6.33e-06	0.000201	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ALB—hematologic cancer	6.25e-06	0.000199	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ALB—hematologic cancer	6.25e-06	0.000199	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CDKN1B—hematologic cancer	6.19e-06	0.000197	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3R1—hematologic cancer	5.98e-06	0.00019	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3R1—hematologic cancer	5.98e-06	0.00019	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CG—hematologic cancer	5.87e-06	0.000187	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CDKN1A—hematologic cancer	5.71e-06	0.000181	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTEN—hematologic cancer	5.7e-06	0.000181	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CB—hematologic cancer	5.52e-06	0.000175	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CB—hematologic cancer	5.52e-06	0.000175	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3CG—hematologic cancer	5.46e-06	0.000174	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CREBBP—hematologic cancer	5.45e-06	0.000173	CbGpPWpGaD
Ribavirin—ENPP1—Disease—EP300—hematologic cancer	5.43e-06	0.000173	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SRC—hematologic cancer	5.28e-06	0.000168	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CD—hematologic cancer	5.16e-06	0.000164	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ALB—hematologic cancer	5.1e-06	0.000162	CbGpPWpGaD
Ribavirin—ENPP1—Disease—STAT3—hematologic cancer	5.1e-06	0.000162	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NRAS—hematologic cancer	5.08e-06	0.000162	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CREBBP—hematologic cancer	5.06e-06	0.000161	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3R1—hematologic cancer	4.88e-06	0.000155	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MAPK3—hematologic cancer	4.87e-06	0.000155	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3CD—hematologic cancer	4.8e-06	0.000153	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTEN—hematologic cancer	4.77e-06	0.000152	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTEN—hematologic cancer	4.77e-06	0.000152	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ALB—hematologic cancer	4.74e-06	0.000151	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MYC—hematologic cancer	4.73e-06	0.00015	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TGFB1—hematologic cancer	4.72e-06	0.00015	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—EP300—hematologic cancer	4.55e-06	0.000145	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—EP300—hematologic cancer	4.55e-06	0.000145	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3R1—hematologic cancer	4.53e-06	0.000144	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CB—hematologic cancer	4.5e-06	0.000143	CbGpPWpGaD
Ribavirin—ENPP1—Disease—KRAS—hematologic cancer	4.37e-06	0.000139	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3CB—hematologic cancer	4.18e-06	0.000133	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3CA—hematologic cancer	4.02e-06	0.000128	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTEN—hematologic cancer	3.89e-06	0.000124	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HRAS—hematologic cancer	3.72e-06	0.000118	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—EP300—hematologic cancer	3.71e-06	0.000118	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTEN—hematologic cancer	3.62e-06	0.000115	CbGpPWpGaD
Ribavirin—ENPP1—Disease—IL6—hematologic cancer	3.56e-06	0.000113	CbGpPWpGaD
Ribavirin—ADK—Metabolism—EP300—hematologic cancer	3.45e-06	0.00011	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CA—hematologic cancer	3.37e-06	0.000107	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CA—hematologic cancer	3.37e-06	0.000107	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKT1—hematologic cancer	3.28e-06	0.000104	CbGpPWpGaD
Ribavirin—Feeling abnormal—Betamethasone—hematologic cancer	3.18e-06	3.99e-05	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—hematologic cancer	3.17e-06	3.98e-05	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—hematologic cancer	3.17e-06	3.98e-05	CcSEcCtD
Ribavirin—Flatulence—Epirubicin—hematologic cancer	3.17e-06	3.98e-05	CcSEcCtD
Ribavirin—Tension—Epirubicin—hematologic cancer	3.16e-06	3.96e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Betamethasone—hematologic cancer	3.15e-06	3.96e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.15e-06	3.96e-05	CcSEcCtD
Ribavirin—Dysgeusia—Epirubicin—hematologic cancer	3.15e-06	3.96e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Triamcinolone—hematologic cancer	3.13e-06	3.93e-05	CcSEcCtD
Ribavirin—Nervousness—Epirubicin—hematologic cancer	3.12e-06	3.92e-05	CcSEcCtD
Ribavirin—Back pain—Epirubicin—hematologic cancer	3.11e-06	3.91e-05	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—hematologic cancer	3.1e-06	3.9e-05	CcSEcCtD
Ribavirin—Malaise—Methotrexate—hematologic cancer	3.1e-06	3.89e-05	CcSEcCtD
Ribavirin—Dizziness—Etoposide—hematologic cancer	3.1e-06	3.89e-05	CcSEcCtD
Ribavirin—Muscle spasms—Epirubicin—hematologic cancer	3.09e-06	3.88e-05	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—hematologic cancer	3.09e-06	3.88e-05	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—hematologic cancer	3.09e-06	3.88e-05	CcSEcCtD
Ribavirin—Mediastinal disorder—Doxorubicin—hematologic cancer	3.08e-06	3.87e-05	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—hematologic cancer	3.08e-06	3.86e-05	CcSEcCtD
Ribavirin—Chills—Doxorubicin—hematologic cancer	3.07e-06	3.85e-05	CcSEcCtD
Ribavirin—Urticaria—Dexamethasone—hematologic cancer	3.06e-06	3.84e-05	CcSEcCtD
Ribavirin—Urticaria—Betamethasone—hematologic cancer	3.06e-06	3.84e-05	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.06e-06	3.84e-05	CcSEcCtD
Ribavirin—Dizziness—Prednisolone—hematologic cancer	3.05e-06	3.84e-05	CcSEcCtD
Ribavirin—Arrhythmia—Doxorubicin—hematologic cancer	3.05e-06	3.84e-05	CcSEcCtD
Ribavirin—Asthenia—Triamcinolone—hematologic cancer	3.05e-06	3.83e-05	CcSEcCtD
Ribavirin—Body temperature increased—Betamethasone—hematologic cancer	3.05e-06	3.83e-05	CcSEcCtD
Ribavirin—Abdominal pain—Betamethasone—hematologic cancer	3.05e-06	3.83e-05	CcSEcCtD
Ribavirin—Abdominal pain—Dexamethasone—hematologic cancer	3.05e-06	3.83e-05	CcSEcCtD
Ribavirin—Body temperature increased—Dexamethasone—hematologic cancer	3.05e-06	3.83e-05	CcSEcCtD
Ribavirin—Nausea—Cisplatin—hematologic cancer	3.04e-06	3.81e-05	CcSEcCtD
Ribavirin—Insomnia—Prednisone—hematologic cancer	3.04e-06	3.81e-05	CcSEcCtD
Ribavirin—Vision blurred—Epirubicin—hematologic cancer	3.03e-06	3.81e-05	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—hematologic cancer	3.02e-06	3.79e-05	CcSEcCtD
Ribavirin—Paraesthesia—Prednisone—hematologic cancer	3.01e-06	3.78e-05	CcSEcCtD
Ribavirin—Pruritus—Triamcinolone—hematologic cancer	3.01e-06	3.77e-05	CcSEcCtD
Ribavirin—Cough—Methotrexate—hematologic cancer	3e-06	3.77e-05	CcSEcCtD
Ribavirin—Mental disorder—Doxorubicin—hematologic cancer	3e-06	3.76e-05	CcSEcCtD
Ribavirin—Ill-defined disorder—Epirubicin—hematologic cancer	2.98e-06	3.75e-05	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—hematologic cancer	2.98e-06	3.74e-05	CcSEcCtD
Ribavirin—Vomiting—Etoposide—hematologic cancer	2.98e-06	3.74e-05	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—hematologic cancer	2.98e-06	3.74e-05	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—hematologic cancer	2.98e-06	3.74e-05	CcSEcCtD
Ribavirin—Anaemia—Epirubicin—hematologic cancer	2.97e-06	3.73e-05	CcSEcCtD
Ribavirin—Agitation—Epirubicin—hematologic cancer	2.96e-06	3.71e-05	CcSEcCtD
Ribavirin—Dyspepsia—Prednisone—hematologic cancer	2.95e-06	3.71e-05	CcSEcCtD
Ribavirin—Rash—Etoposide—hematologic cancer	2.95e-06	3.71e-05	CcSEcCtD
Ribavirin—Dermatitis—Etoposide—hematologic cancer	2.95e-06	3.7e-05	CcSEcCtD
Ribavirin—Headache—Etoposide—hematologic cancer	2.93e-06	3.68e-05	CcSEcCtD
Ribavirin—Flatulence—Doxorubicin—hematologic cancer	2.93e-06	3.68e-05	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—hematologic cancer	2.93e-06	3.67e-05	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—hematologic cancer	2.93e-06	3.67e-05	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—hematologic cancer	2.93e-06	3.67e-05	CcSEcCtD
Ribavirin—Tension—Doxorubicin—hematologic cancer	2.92e-06	3.67e-05	CcSEcCtD
Ribavirin—Decreased appetite—Prednisone—hematologic cancer	2.92e-06	3.66e-05	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—hematologic cancer	2.91e-06	3.66e-05	CcSEcCtD
Ribavirin—Rash—Prednisolone—hematologic cancer	2.91e-06	3.66e-05	CcSEcCtD
Ribavirin—Dermatitis—Prednisolone—hematologic cancer	2.91e-06	3.65e-05	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.91e-06	3.65e-05	CcSEcCtD
Ribavirin—Malaise—Epirubicin—hematologic cancer	2.9e-06	3.64e-05	CcSEcCtD
Ribavirin—Fatigue—Prednisone—hematologic cancer	2.89e-06	3.63e-05	CcSEcCtD
Ribavirin—Headache—Prednisolone—hematologic cancer	2.89e-06	3.63e-05	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—hematologic cancer	2.89e-06	3.63e-05	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—hematologic cancer	2.89e-06	3.63e-05	CcSEcCtD
Ribavirin—Vertigo—Epirubicin—hematologic cancer	2.89e-06	3.63e-05	CcSEcCtD
Ribavirin—Syncope—Epirubicin—hematologic cancer	2.88e-06	3.62e-05	CcSEcCtD
Ribavirin—Leukopenia—Epirubicin—hematologic cancer	2.88e-06	3.62e-05	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—hematologic cancer	2.88e-06	3.62e-05	CcSEcCtD
Ribavirin—Constipation—Prednisone—hematologic cancer	2.87e-06	3.6e-05	CcSEcCtD
Ribavirin—Muscle spasms—Doxorubicin—hematologic cancer	2.86e-06	3.59e-05	CcSEcCtD
Ribavirin—Palpitations—Epirubicin—hematologic cancer	2.84e-06	3.57e-05	CcSEcCtD
Ribavirin—Confusional state—Methotrexate—hematologic cancer	2.83e-06	3.55e-05	CcSEcCtD
Ribavirin—Loss of consciousness—Epirubicin—hematologic cancer	2.83e-06	3.55e-05	CcSEcCtD
Ribavirin—Dizziness—Triamcinolone—hematologic cancer	2.81e-06	3.53e-05	CcSEcCtD
Ribavirin—Cough—Epirubicin—hematologic cancer	2.81e-06	3.52e-05	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—hematologic cancer	2.81e-06	3.52e-05	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—hematologic cancer	2.8e-06	3.52e-05	CcSEcCtD
Ribavirin—Convulsion—Epirubicin—hematologic cancer	2.79e-06	3.5e-05	CcSEcCtD
Ribavirin—Nausea—Etoposide—hematologic cancer	2.78e-06	3.49e-05	CcSEcCtD
Ribavirin—Hypertension—Epirubicin—hematologic cancer	2.78e-06	3.49e-05	CcSEcCtD
Ribavirin—Feeling abnormal—Prednisone—hematologic cancer	2.77e-06	3.47e-05	CcSEcCtD
Ribavirin—Asthenia—Dexamethasone—hematologic cancer	2.77e-06	3.47e-05	CcSEcCtD
Ribavirin—Asthenia—Betamethasone—hematologic cancer	2.77e-06	3.47e-05	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—hematologic cancer	2.76e-06	3.47e-05	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—hematologic cancer	2.75e-06	3.45e-05	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—hematologic cancer	2.75e-06	3.45e-05	CcSEcCtD
Ribavirin—NT5C2—Metabolism—AKT1—hematologic cancer	2.75e-06	8.74e-05	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKT1—hematologic cancer	2.75e-06	8.74e-05	CbGpPWpGaD
Ribavirin—Thrombocytopenia—Methotrexate—hematologic cancer	2.75e-06	3.45e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Prednisone—hematologic cancer	2.74e-06	3.45e-05	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PIK3CA—hematologic cancer	2.74e-06	8.72e-05	CbGpPWpGaD
Ribavirin—Nausea—Prednisolone—hematologic cancer	2.74e-06	3.45e-05	CcSEcCtD
Ribavirin—Arthralgia—Epirubicin—hematologic cancer	2.74e-06	3.44e-05	CcSEcCtD
Ribavirin—Myalgia—Epirubicin—hematologic cancer	2.74e-06	3.44e-05	CcSEcCtD
Ribavirin—Chest pain—Epirubicin—hematologic cancer	2.74e-06	3.44e-05	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—hematologic cancer	2.74e-06	3.43e-05	CcSEcCtD
Ribavirin—Anxiety—Epirubicin—hematologic cancer	2.73e-06	3.43e-05	CcSEcCtD
Ribavirin—Pruritus—Betamethasone—hematologic cancer	2.73e-06	3.42e-05	CcSEcCtD
Ribavirin—Pruritus—Dexamethasone—hematologic cancer	2.73e-06	3.42e-05	CcSEcCtD
Ribavirin—Skin disorder—Methotrexate—hematologic cancer	2.72e-06	3.42e-05	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.72e-06	3.42e-05	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—hematologic cancer	2.71e-06	3.41e-05	CcSEcCtD
Ribavirin—Discomfort—Epirubicin—hematologic cancer	2.71e-06	3.4e-05	CcSEcCtD
Ribavirin—Vomiting—Triamcinolone—hematologic cancer	2.7e-06	3.39e-05	CcSEcCtD
Ribavirin—Malaise—Doxorubicin—hematologic cancer	2.68e-06	3.37e-05	CcSEcCtD
Ribavirin—Rash—Triamcinolone—hematologic cancer	2.68e-06	3.36e-05	CcSEcCtD
Ribavirin—Dry mouth—Epirubicin—hematologic cancer	2.68e-06	3.36e-05	CcSEcCtD
Ribavirin—Dermatitis—Triamcinolone—hematologic cancer	2.68e-06	3.36e-05	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—hematologic cancer	2.67e-06	3.36e-05	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—hematologic cancer	2.67e-06	3.36e-05	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—hematologic cancer	2.67e-06	3.35e-05	CcSEcCtD
Ribavirin—Urticaria—Prednisone—hematologic cancer	2.67e-06	3.35e-05	CcSEcCtD
Ribavirin—Leukopenia—Doxorubicin—hematologic cancer	2.66e-06	3.35e-05	CcSEcCtD
Ribavirin—Headache—Triamcinolone—hematologic cancer	2.66e-06	3.34e-05	CcSEcCtD
Ribavirin—Body temperature increased—Prednisone—hematologic cancer	2.65e-06	3.33e-05	CcSEcCtD
Ribavirin—Abdominal pain—Prednisone—hematologic cancer	2.65e-06	3.33e-05	CcSEcCtD
Ribavirin—Confusional state—Epirubicin—hematologic cancer	2.65e-06	3.32e-05	CcSEcCtD
Ribavirin—Diarrhoea—Betamethasone—hematologic cancer	2.64e-06	3.31e-05	CcSEcCtD
Ribavirin—Diarrhoea—Dexamethasone—hematologic cancer	2.64e-06	3.31e-05	CcSEcCtD
Ribavirin—Palpitations—Doxorubicin—hematologic cancer	2.63e-06	3.3e-05	CcSEcCtD
Ribavirin—Oedema—Epirubicin—hematologic cancer	2.63e-06	3.3e-05	CcSEcCtD
Ribavirin—Anaphylactic shock—Epirubicin—hematologic cancer	2.63e-06	3.3e-05	CcSEcCtD
Ribavirin—Hypotension—Methotrexate—hematologic cancer	2.62e-06	3.29e-05	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—hematologic cancer	2.62e-06	3.28e-05	CcSEcCtD
Ribavirin—Cough—Doxorubicin—hematologic cancer	2.6e-06	3.26e-05	CcSEcCtD
Ribavirin—Shock—Epirubicin—hematologic cancer	2.58e-06	3.24e-05	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—hematologic cancer	2.58e-06	3.24e-05	CcSEcCtD
Ribavirin—Nervous system disorder—Epirubicin—hematologic cancer	2.57e-06	3.23e-05	CcSEcCtD
Ribavirin—Thrombocytopenia—Epirubicin—hematologic cancer	2.57e-06	3.23e-05	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—hematologic cancer	2.57e-06	3.23e-05	CcSEcCtD
Ribavirin—Tachycardia—Epirubicin—hematologic cancer	2.56e-06	3.22e-05	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.56e-06	3.21e-05	CcSEcCtD
Ribavirin—ADK—Metabolism—PIK3CA—hematologic cancer	2.55e-06	8.11e-05	CbGpPWpGaD
Ribavirin—Skin disorder—Epirubicin—hematologic cancer	2.55e-06	3.2e-05	CcSEcCtD
Ribavirin—Dizziness—Dexamethasone—hematologic cancer	2.55e-06	3.2e-05	CcSEcCtD
Ribavirin—Dizziness—Betamethasone—hematologic cancer	2.55e-06	3.2e-05	CcSEcCtD
Ribavirin—Hyperhidrosis—Epirubicin—hematologic cancer	2.54e-06	3.19e-05	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—hematologic cancer	2.54e-06	3.19e-05	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—hematologic cancer	2.53e-06	3.18e-05	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—hematologic cancer	2.53e-06	3.18e-05	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—hematologic cancer	2.53e-06	3.18e-05	CcSEcCtD
Ribavirin—Anxiety—Doxorubicin—hematologic cancer	2.53e-06	3.17e-05	CcSEcCtD
Ribavirin—Nausea—Triamcinolone—hematologic cancer	2.52e-06	3.17e-05	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—hematologic cancer	2.52e-06	3.16e-05	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.52e-06	3.16e-05	CcSEcCtD
Ribavirin—Discomfort—Doxorubicin—hematologic cancer	2.5e-06	3.14e-05	CcSEcCtD
Ribavirin—Anorexia—Epirubicin—hematologic cancer	2.5e-06	3.14e-05	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—hematologic cancer	2.5e-06	3.14e-05	CcSEcCtD
Ribavirin—Somnolence—Methotrexate—hematologic cancer	2.49e-06	3.13e-05	CcSEcCtD
Ribavirin—Dry mouth—Doxorubicin—hematologic cancer	2.48e-06	3.11e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Prednisone—hematologic cancer	2.47e-06	3.11e-05	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—hematologic cancer	2.47e-06	3.1e-05	CcSEcCtD
Ribavirin—Hypotension—Epirubicin—hematologic cancer	2.45e-06	3.08e-05	CcSEcCtD
Ribavirin—Vomiting—Dexamethasone—hematologic cancer	2.45e-06	3.08e-05	CcSEcCtD
Ribavirin—Vomiting—Betamethasone—hematologic cancer	2.45e-06	3.08e-05	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—hematologic cancer	2.45e-06	3.08e-05	CcSEcCtD
Ribavirin—Decreased appetite—Methotrexate—hematologic cancer	2.44e-06	3.06e-05	CcSEcCtD
Ribavirin—Rash—Betamethasone—hematologic cancer	2.43e-06	3.05e-05	CcSEcCtD
Ribavirin—Rash—Dexamethasone—hematologic cancer	2.43e-06	3.05e-05	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—hematologic cancer	2.43e-06	3.05e-05	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.43e-06	3.05e-05	CcSEcCtD
Ribavirin—Dermatitis—Dexamethasone—hematologic cancer	2.43e-06	3.05e-05	CcSEcCtD
Ribavirin—Dermatitis—Betamethasone—hematologic cancer	2.43e-06	3.05e-05	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.42e-06	3.04e-05	CcSEcCtD
Ribavirin—Fatigue—Methotrexate—hematologic cancer	2.42e-06	3.04e-05	CcSEcCtD
Ribavirin—Headache—Dexamethasone—hematologic cancer	2.41e-06	3.03e-05	CcSEcCtD
Ribavirin—Headache—Betamethasone—hematologic cancer	2.41e-06	3.03e-05	CcSEcCtD
Ribavirin—Asthenia—Prednisone—hematologic cancer	2.41e-06	3.02e-05	CcSEcCtD
Ribavirin—Pain—Methotrexate—hematologic cancer	2.4e-06	3.01e-05	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.39e-06	3e-05	CcSEcCtD
Ribavirin—Shock—Doxorubicin—hematologic cancer	2.39e-06	3e-05	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—hematologic cancer	2.38e-06	2.99e-05	CcSEcCtD
Ribavirin—Thrombocytopenia—Doxorubicin—hematologic cancer	2.38e-06	2.99e-05	CcSEcCtD
Ribavirin—Pruritus—Prednisone—hematologic cancer	2.37e-06	2.98e-05	CcSEcCtD
Ribavirin—Insomnia—Epirubicin—hematologic cancer	2.37e-06	2.98e-05	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—hematologic cancer	2.37e-06	2.98e-05	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—hematologic cancer	2.36e-06	2.96e-05	CcSEcCtD
Ribavirin—Paraesthesia—Epirubicin—hematologic cancer	2.36e-06	2.96e-05	CcSEcCtD
Ribavirin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.35e-06	2.95e-05	CcSEcCtD
Ribavirin—Dyspnoea—Epirubicin—hematologic cancer	2.34e-06	2.94e-05	CcSEcCtD
Ribavirin—Somnolence—Epirubicin—hematologic cancer	2.33e-06	2.93e-05	CcSEcCtD
Ribavirin—Anorexia—Doxorubicin—hematologic cancer	2.32e-06	2.91e-05	CcSEcCtD
Ribavirin—Feeling abnormal—Methotrexate—hematologic cancer	2.31e-06	2.9e-05	CcSEcCtD
Ribavirin—Dyspepsia—Epirubicin—hematologic cancer	2.31e-06	2.9e-05	CcSEcCtD
Ribavirin—Diarrhoea—Prednisone—hematologic cancer	2.3e-06	2.88e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.29e-06	2.88e-05	CcSEcCtD
Ribavirin—Nausea—Betamethasone—hematologic cancer	2.29e-06	2.87e-05	CcSEcCtD
Ribavirin—Nausea—Dexamethasone—hematologic cancer	2.29e-06	2.87e-05	CcSEcCtD
Ribavirin—Decreased appetite—Epirubicin—hematologic cancer	2.28e-06	2.87e-05	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—hematologic cancer	2.27e-06	2.85e-05	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.27e-06	2.85e-05	CcSEcCtD
Ribavirin—Fatigue—Epirubicin—hematologic cancer	2.26e-06	2.84e-05	CcSEcCtD
Ribavirin—Pain—Epirubicin—hematologic cancer	2.24e-06	2.82e-05	CcSEcCtD
Ribavirin—Constipation—Epirubicin—hematologic cancer	2.24e-06	2.82e-05	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—AKT1—hematologic cancer	2.24e-06	7.12e-05	CbGpPWpGaD
Ribavirin—Urticaria—Methotrexate—hematologic cancer	2.23e-06	2.8e-05	CcSEcCtD
Ribavirin—Dizziness—Prednisone—hematologic cancer	2.22e-06	2.79e-05	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—hematologic cancer	2.22e-06	2.78e-05	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—hematologic cancer	2.22e-06	2.78e-05	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.21e-06	2.78e-05	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—hematologic cancer	2.2e-06	2.76e-05	CcSEcCtD
Ribavirin—Paraesthesia—Doxorubicin—hematologic cancer	2.18e-06	2.74e-05	CcSEcCtD
Ribavirin—Dyspnoea—Doxorubicin—hematologic cancer	2.17e-06	2.72e-05	CcSEcCtD
Ribavirin—Feeling abnormal—Epirubicin—hematologic cancer	2.16e-06	2.72e-05	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—hematologic cancer	2.16e-06	2.71e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.15e-06	2.7e-05	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—hematologic cancer	2.14e-06	2.68e-05	CcSEcCtD
Ribavirin—Vomiting—Prednisone—hematologic cancer	2.13e-06	2.68e-05	CcSEcCtD
Ribavirin—Rash—Prednisone—hematologic cancer	2.12e-06	2.66e-05	CcSEcCtD
Ribavirin—Dermatitis—Prednisone—hematologic cancer	2.11e-06	2.66e-05	CcSEcCtD
Ribavirin—Decreased appetite—Doxorubicin—hematologic cancer	2.11e-06	2.65e-05	CcSEcCtD
Ribavirin—Headache—Prednisone—hematologic cancer	2.1e-06	2.64e-05	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.1e-06	2.63e-05	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—hematologic cancer	2.09e-06	2.63e-05	CcSEcCtD
Ribavirin—Urticaria—Epirubicin—hematologic cancer	2.09e-06	2.62e-05	CcSEcCtD
Ribavirin—ADK—Metabolism—AKT1—hematologic cancer	2.08e-06	6.62e-05	CbGpPWpGaD
Ribavirin—Constipation—Doxorubicin—hematologic cancer	2.08e-06	2.61e-05	CcSEcCtD
Ribavirin—Pain—Doxorubicin—hematologic cancer	2.08e-06	2.61e-05	CcSEcCtD
Ribavirin—Abdominal pain—Epirubicin—hematologic cancer	2.08e-06	2.61e-05	CcSEcCtD
Ribavirin—Body temperature increased—Epirubicin—hematologic cancer	2.08e-06	2.61e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Methotrexate—hematologic cancer	2.07e-06	2.6e-05	CcSEcCtD
Ribavirin—Asthenia—Methotrexate—hematologic cancer	2.01e-06	2.53e-05	CcSEcCtD
Ribavirin—Feeling abnormal—Doxorubicin—hematologic cancer	2e-06	2.51e-05	CcSEcCtD
Ribavirin—Nausea—Prednisone—hematologic cancer	1.99e-06	2.5e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.99e-06	2.49e-05	CcSEcCtD
Ribavirin—Pruritus—Methotrexate—hematologic cancer	1.98e-06	2.49e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Epirubicin—hematologic cancer	1.93e-06	2.43e-05	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—hematologic cancer	1.93e-06	2.42e-05	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—hematologic cancer	1.92e-06	2.41e-05	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—hematologic cancer	1.92e-06	2.41e-05	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—hematologic cancer	1.92e-06	2.41e-05	CcSEcCtD
Ribavirin—Asthenia—Epirubicin—hematologic cancer	1.88e-06	2.37e-05	CcSEcCtD
Ribavirin—Pruritus—Epirubicin—hematologic cancer	1.86e-06	2.33e-05	CcSEcCtD
Ribavirin—Dizziness—Methotrexate—hematologic cancer	1.85e-06	2.33e-05	CcSEcCtD
Ribavirin—Diarrhoea—Epirubicin—hematologic cancer	1.8e-06	2.26e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—hematologic cancer	1.79e-06	2.25e-05	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—hematologic cancer	1.78e-06	2.24e-05	CcSEcCtD
Ribavirin—Rash—Methotrexate—hematologic cancer	1.77e-06	2.22e-05	CcSEcCtD
Ribavirin—Dermatitis—Methotrexate—hematologic cancer	1.77e-06	2.22e-05	CcSEcCtD
Ribavirin—Headache—Methotrexate—hematologic cancer	1.76e-06	2.21e-05	CcSEcCtD
Ribavirin—Asthenia—Doxorubicin—hematologic cancer	1.74e-06	2.19e-05	CcSEcCtD
Ribavirin—Dizziness—Epirubicin—hematologic cancer	1.74e-06	2.18e-05	CcSEcCtD
Ribavirin—Pruritus—Doxorubicin—hematologic cancer	1.72e-06	2.16e-05	CcSEcCtD
Ribavirin—Vomiting—Epirubicin—hematologic cancer	1.67e-06	2.1e-05	CcSEcCtD
Ribavirin—Nausea—Methotrexate—hematologic cancer	1.67e-06	2.09e-05	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—hematologic cancer	1.66e-06	2.09e-05	CcSEcCtD
Ribavirin—Rash—Epirubicin—hematologic cancer	1.66e-06	2.08e-05	CcSEcCtD
Ribavirin—Dermatitis—Epirubicin—hematologic cancer	1.65e-06	2.08e-05	CcSEcCtD
Ribavirin—Headache—Epirubicin—hematologic cancer	1.64e-06	2.07e-05	CcSEcCtD
Ribavirin—Dizziness—Doxorubicin—hematologic cancer	1.61e-06	2.02e-05	CcSEcCtD
Ribavirin—Nausea—Epirubicin—hematologic cancer	1.56e-06	1.96e-05	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—hematologic cancer	1.54e-06	1.94e-05	CcSEcCtD
Ribavirin—Rash—Doxorubicin—hematologic cancer	1.53e-06	1.92e-05	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—hematologic cancer	1.53e-06	1.92e-05	CcSEcCtD
Ribavirin—Headache—Doxorubicin—hematologic cancer	1.52e-06	1.91e-05	CcSEcCtD
Ribavirin—Nausea—Doxorubicin—hematologic cancer	1.44e-06	1.81e-05	CcSEcCtD
